Brendan Luu insider trades

Open-market stock purchases and sales by Brendan Luu, Chief Business Officer at Enanta Pharmaceuticals Inc, from SEC Form 4 filings since Jan 25, 2021.

Recent trades

DateStockTradeValue
Feb 12, 2026ENTA Enanta Pharmaceuticals IncBought (not open market)—
Feb 12, 2026ENTA Enanta Pharmaceuticals IncBought (not open market)—
Feb 12, 2026ENTA Enanta Pharmaceuticals IncSold (not open market)$46.4K
Dec 5, 2025ENTA Enanta Pharmaceuticals IncSold$19.8K
Dec 1, 2025ENTA Enanta Pharmaceuticals IncSold (not open market)$7K
Nov 25, 2025ENTA Enanta Pharmaceuticals IncBought (not open market)—

Companies traded

  • ENTA Enanta Pharmaceuticals Inc: 3 sales, last Feb 12, 2026

Get free alerts when Brendan Luu files a new trade →